Breaks Categories: News

TuesdayMar 06, 2018 11:16 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Announces Acquisition of Thrudermic, LLC

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) this morning announced its acquisition of Thrudermic, LLC, a privately-held North Carolina company. Per the update, Pivot will pay $1.00 for all of the listed and outstanding units of Thrudermic and issue an aggregate of 500,000 shares in the capital of Pivot to Dr. Joseph Borovsky and Dr. Leonid Lurya for their intellectual property portfolio, including patents, good will and know-how in connection with Thrudermic’s Transdermal Nanotechnology. Additionally, Borovsky has been appointed Pivot’s vice president, product formulation, and Lurya has been appointed Pivot’s executive director, product formulation. “Thrudermic is Pivot's…

Continue Reading

TuesdayMar 06, 2018 10:01 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Posts Business Update

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) this morning released an update regarding the company’s recent achievements and plans moving forward. Per the update, the company intends to use its recent financing of $75 million, which brought the company’s cash to over $135 million, to accelerate its growth through a disciplined capital allocation process. Abcann intends to expand its production capacity, focus on branding and product innovation, expand its Harvest Medicine platform to new locations and develop strategic partnerships in the industry. “Over the past five months we have enhanced our leadership team, strengthened our balance sheet, improved operational effectiveness and…

Continue Reading

MondayMar 05, 2018 9:24 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Successfully Completes C$5M Private Placement of Convertible Debentures

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) this morning announced the closing of its private placement of convertible debentures for gross proceeds totaling C$5 million. The company issued a total of C$5 million of 10% senior secured convertible debentures which will mature 12 months after the date of their issuance and will be convertible at the option of the holder for a period of 12 months into common shares of the company at a conversion price of C$1.74 per common share, subject to adjustment of the conversion price in certain events. Additionally, Origin Merchant Securities Inc. received a finder’s fee of…

Continue Reading

FridayMar 02, 2018 9:27 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Receives Processing Approval from Depository Trust Company

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced that it has received processing approval from The Depository Trust Company (“DTC”) of New York and, as a result, is now DTC eligible. The DTC is a subsidiary of the Depository Trust & Clearing Corporation that manages electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through DTC enjoy expedited receipt of stock and cash, which translates to an accelerated settlement process for investors. Per the update, being DTC eligible is expected to greatly simplify the…

Continue Reading

ThursdayMar 01, 2018 10:08 am

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Subsidiary Inks Deal with Cannabis Compliance Inc.

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) president and CEO Will Rascan this morning announced that the company’s wholly-owned subsidiary, North Road Ventures, has signed an agreement with Cannabis Compliance Inc. ("CCI"). Per the terms of the agreement, CCI will be responsible for assuring the Good Manufacturing Practice (“GMP”)-compliant processing and production of North Road's products containing cannabis. GMP requirements ensure that the products manufactured are safe and of consistently high quality for their intended use. "This opens the door for North Road to obtain industry certification and regulatory authorization and/or licensing, as needed. It facilitates the…

Continue Reading

ThursdayMar 01, 2018 9:18 am

CannabisNewsBreaks – Hiku Brands Company Ltd. (CSE: HIKU) (OTC: DJACF) Subsidiary Completes Pre-Sales Inspection at West Kelowna

Canada’s first vertically-integrated cannabis brand house, Hiku Brands Company Ltd. (CSE: HIKU) (OTC: DJACF), through its DOJA Cannabis Ltd. subsidiary, this morning announced that it has completed Health Canada’s pre-sales license inspection of its West Kelowna facility. Per the update, Health Canada inspectors were onsite at the West Kelowna project throughout a three-day period ended on February 15, 2018, in an effort to verify the information submitted by DOJA as part of its application and assess the company’s compliance with applicable sections of the Access to Cannabis for Medical Purposes Regulations. This milestone is particularly noteworthy as it coincides with…

Continue Reading

WednesdayFeb 28, 2018 9:26 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Adds Senior Vice President of Marketing

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced its appointment of Chris Gagan to the position of Senior Vice President of Marketing in a move that’s expected to play a key role in refining the company’s brand strategy. Gagan bring more than two decades of marketing and brand development experience to Choom, having previously led the design and development team for Canada’s largest national retailer of sporting goods, FGL Sports. As Choom’s Senior Vice President of Marketing, Gagan will provide leadership and guidance related to the execution of the company’s marketing efforts, as…

Continue Reading

WednesdayFeb 28, 2018 9:25 am

CannabisNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Inks MOU with BioCan Technologies

Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP), a pharmaceutical and IP development firm, this morning announced that it has entered into a Memorandum of Understanding (“MOU”) with BioCan Technologies Inc. of Calgary, Alberta to collaborate exclusively to conduct additional investigations of cannabis strains being developed by Veritas’ research arm, Cannevert Therapeutics Ltd. (“CTL”). Optimizing the genetics of the cannabis plants for scientific and clinical testing over the next two years is the company’s primary focus during the collaboration. Definitive agreements relating to the MOU are anticipated to be signed by July 31, 2018. “BioCan’s geneticists will help CTL scientists…

Continue Reading

TuesdayFeb 27, 2018 3:33 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) CEO, Chief Research Officer Discuss Company’s Response to Opioid Epidemic

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) was featured in an interview today by Proactive Investors. Chairman and CEO Stephen Van Deventer and chief research officer Dr. Harry Parekh discussed the company’s four programs: Sol-Gel, Nature Identical™, Dual Gene Therapy and Engineering Peptide Therapeutics. Among other topics, they discuss the rising rate of opioid overdoses and addiction, which the company’s planning to tackle utilizing its proprietary linker technology to engineer peptide therapeutics. “What's key about the technology is you cannot create tolerance to this treatment and you cannot overdose as well,” PreveCeutical chairman and CEO…

Continue Reading

TuesdayFeb 27, 2018 11:28 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Completes Acquisition of ERS Holdings; Announces Private Placement of Convertible Debentures

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) this morning announced the successful completion of its acquisition of ERS Holdings, LLC (“ERS”). ERS, a privately-held California company, has developed a patented technology called Ready-To-Infuse-Cannabis (“RTIC”) which covers the transformation of cannabis oil into powder for infusion into various food and beverage products. In addition, ERS has filed several continuation patents that would permit cannabis powder to be combined with other health and wellness products such as natural sleep-aids, cold medications and vitamins. Ross Franklin, co-inventor of the patent, has been appointed as the Director of Research and Development of ERS and…

Continue Reading